Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,533 | -83,463 | -55,025 | -30,459 | -14,185 |
| Depreciation Amortization | 165 | 51 | 17 | 11 | 5 |
| Accounts payable and accrued liabilities | 1,553 | 3,290 | 3,620 | 5,802 | 7,346 |
| Other Working Capital | -2,125 | -4,027 | -4,293 | 450 | 7,187 |
| Other Operating Activity | 4,266 | 16,048 | 5,068 | -1,561 | -5,488 |
| Operating Cash Flow | $-20,674 | $-68,101 | $-50,613 | $-25,757 | $-5,135 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -589 | -4,923 | -405 | -7 | -7 |
| Purchase Of Investment | -183,332 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-183,921 | $-4,923 | $-405 | $-7 | $-7 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -105 | -281 | -177 | -73 | N/A |
| Common Stock Issued | 185 | 2,753 | 2,125 | 1,582 | 778 |
| Financing Cash Flow | $80 | $2,472 | $1,948 | $1,509 | $778 |
| Beginning Cash Position | 363,667 | 434,219 | 434,219 | 434,219 | 434,219 |
| End Cash Position | 159,152 | 363,667 | 385,149 | 409,964 | 429,855 |
| Net Cash Flow | $-204,515 | $-70,552 | $-49,070 | $-24,255 | $-4,364 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,674 | -68,101 | -50,613 | -25,757 | -5,135 |
| Capital Expenditure | -589 | -4,923 | -405 | -7 | -7 |
| Free Cash Flow | -21,263 | -73,024 | -51,018 | -25,764 | -5,142 |